Literature DB >> 10833264

Role of myeloperoxidase in the neutrophil-induced oxidation of low density lipoprotein as studied by myeloperoxidase-knockout mouse.

N Noguchi1, K Nakano, Y Aratani, H Koyama, T Kodama, E Niki.   

Abstract

Low density lipoprotein was oxidized by neutrophils derived from either C57BL/6 mice or myeloperoxidase (MPO)-knockout mice. The generation of superoxide from neutrophils of MPO-knockout mice was about 70% of that from wild-type mice. The extent of the oxidation of human low density lipoprotein (LDL) by phorbol myristate acetate (PMA)-activated neutrophils of wild-type and MPO-knockout mice was assessed by measuring consumption of a-tocopherol and formation of phosphatidylcholine hydroperoxide (PCOOH) and cholesteryl ester hydroperoxide (CEOOH). Little consumption of a-tocopherol was observed in both oxidations. It was found, however, that lipid hydroperoxides were accumulated with time in both oxidations and that the rates of formation of PCOOH and CEOOH in the oxidation by MPO-knockout neutrophils were about 66 and 44% of those by wild-type neutrophils, respectively. The lipid peroxidation was completely inhibited by adding superoxide dismutase (SOD) in both cases. The addition of L-tyrosine and SOD enhanced lipid peroxidation of LDL induced by wild-type neutrophils but not by MPO-knockout ones. These results suggest that, regardless of their MPO activity, neutrophils induce lipid peroxidation of LDL by a superoxide-dependent pathway, and that MPO-catalyzed lipid peroxidation is enhanced by the presence of an appropriate amount of free tyrosine and further enhanced by SOD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833264     DOI: 10.1093/oxfordjournals.jbchem.a022713

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  The proper study of mankind.

Authors:  W M Nauseef
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 2.  Effects of antioxidants against atherosclerosis.

Authors:  Etsuo Niki; Noriko Noguchi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

3.  Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils.

Authors:  Mark J White; Jeffrey M Boyd; Alexander R Horswill; William M Nauseef
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

4.  Severe neutrophil-mediated lung inflammation in myeloperoxidase-deficient mice exposed to zymosan.

Authors:  Kazuhiro Takeuchi; Yu Umeki; Noriko Matsumoto; Kei Yamamoto; Mina Yoshida; Kazuo Suzuki; Yasuaki Aratani
Journal:  Inflamm Res       Date:  2011-11-25       Impact factor: 4.575

Review 5.  Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system.

Authors:  W M Nauseef
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

6.  Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.

Authors:  Andreas Ullen; Günter Fauler; Harald Köfeler; Sabine Waltl; Christoph Nusshold; Eva Bernhart; Helga Reicher; Hans-Jörg Leis; Andrea Wintersperger; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2010-08-31       Impact factor: 7.376

7.  Polyunsaturated phospholipids promote the oxidation and fragmentation of gamma-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids.

Authors:  Xi Chen; Wujuan Zhang; James Laird; Stanley L Hazen; Robert G Salomon
Journal:  J Lipid Res       Date:  2007-12-29       Impact factor: 5.922

8.  G-CSF induces membrane expression of a myeloperoxidase glycovariant that operates as an E-selectin ligand on human myeloid cells.

Authors:  Cristina I Silvescu; Robert Sackstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

9.  Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2).

Authors:  Wijtske Annema; Niels Nijstad; Markus Tölle; Jan Freark de Boer; Ruben V C Buijs; Peter Heeringa; Markus van der Giet; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2010-01-08       Impact factor: 5.922

10.  Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing.

Authors:  Pamela R Hall; Bradley O Elmore; Cynthia H Spang; Susan M Alexander; Brett C Manifold-Wheeler; Moriah J Castleman; Seth M Daly; M Michal Peterson; Erin K Sully; Jon K Femling; Michael Otto; Alexander R Horswill; Graham S Timmins; Hattie D Gresham
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.